Navigation Links
Varian Imaging Components President Robert Kluge Announces Plans to Retire; Varian CEO Dow Wilson Names Sunny Sanyal as Kluge's Successor
Date:12/16/2013

PALO ALTO, Calif., Dec. 16, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced that Robert H. Kluge has announced his intention to retire as its Senior Vice President and President, Imaging Components Businesses effective February 7, 2014.  Varian CEO Dow R. Wilson has named and the Board of Directors has appointed Sunny Sanyal, CEO of T-System, to succeed Kluge.  Varian's Imaging Components Businesses are comprised of the X-Ray Products and Security and Inspection Products businesses.

"Bob Kluge built Varian's X-Ray Products revenues from $75 million in 1993 to $546 million at the end of fiscal 2013," Wilson said.  "We are indebted to Bob for his strategic vision, intelligent management, and consistent execution that have propelled Varian to a leadership position in the global imaging industry.  He has set the stage for continued success and growth in our components businesses. 

"Sunny Sanyal is an experienced leader who will work with our seasoned imaging components management team to expand and capitalize on the growth potential for these businesses," Wilson said.  "We look forward under Sunny's leadership to building these businesses into a billion dollar platform for Varian." 

Sanyal, 49, will assume his position as Senior Vice President and President, Imaging Components Businesses on February 3, 2014.  Prior to joining T-System, a privately-held company providing information technology solutions and services to hospitals and urgent care facilities, Sanyal was president of McKesson Provider Technologies, where he led the company to significant market expansion with its clinical IT solutions.  He also worked for GE Healthcare, Accenture and IDX Systems. 

"I am excited to be a part of Varian," Sanyal said.  "Bob and team have built a tremendous business for Varian.  I look forward to working with the team to continue building these businesses through market expansion, continued innovation, and strong customer relationships."

Sanyal has an MBA from Harvard Business School, an MS in Industrial Engineering from Louisiana State University, and a bachelor's degree in Electrical Engineering from the University of Bombay.

Kluge, 67, will retire but support the leadership transition in an advisory capacity as needed.  "I have enjoyed building the X-ray Products business for Varian and I have been fortunate to have great relationships with our customers, Varian management, and the imaging components team," said Kluge. "I expect this team will continue to excel and that these businesses will thrive under Sunny's leadership."  

ABOUT VARIAN MEDICAL SYSTEMS
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 6,400 people who are located at manufacturing sites in North America, Europe, and China and 72 sales and support offices around the world. For more information, visit http://www.varian.com.

Forward-Looking Statements
Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including growth drivers; the company's future orders, revenues, backlog, or earnings growth; future financial results; the ability of the company's technology and products to save lives; and any statements using the terms "will," "continue," "expect," "set the stage," "expand," "look forward," or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company's actual results to differ materially from those anticipated. Such risks and uncertainties include the company's ability to effectively integrate new management; the company's ability to retain the services of key personnel; the effect of global economic conditions; demand for the company's products; the company's ability to develop, commercialize, and deploy new products; the impact of competitive products and pricing; the potential loss of key distributors or partners; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

FOR INFORMATION CONTACT:
Spencer Sias (650) 424-5782
spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems Schedules First Quarter FY2014 News Release and Conference Call
2. Bavarian Nordic, the international novel cancer and infectious disease vaccines focused biotech, now covered by Edison.
3. Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
4. Varian Medical Systems Exhibits New Lightweight Wireless Flat-Panel Digital X-ray Image Detector for Imaging Extremities and for Neonatal Procedures
5. Regina E. Dugan Appointed to Board of Directors of Varian Medical Systems
6. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 6 Million Shares of Stock through Calendar Year 2014
7. Varian Medical Systems Exhibits New Flat-Panel Digital X-ray Image Detectors Designed for High Energy Industrial and Security Applications
8. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions OVA1 Test in Presurgical Detection of Early-Stage Ovarian Cancer
9. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions Ovarian Cancer Test, OVA1
10. EntreMed Commences Phase 2 Trial For ENMD-2076 In Ovarian Clear Cell Carcinomas
11. Merrimack Pharmaceuticals Announces Results From A Phase 2 Study Of MM-121 (SAR256212) In Combination With Paclitaxel In Patients With Platinum-Resistant Or Refractory Advanced Ovarian Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... YORK , March 24, 2017 ... and Equipment stocks, which are: Neovasc Inc. (NASDAQ: NVCN), Hologic ... Heart Inc. (NASDAQ: SSH ). These companies are ... its prior gains on Thursday, March 23 rd , 2017, ... afternoon, while shares of health care companies in the S&P ...
(Date:3/24/2017)... BOTHELL, Wash. , March 23, 2017 /PRNewswire/ ... developer of advanced medical technology for non-invasive surgery, ... the Mirabilis System for treatment of uterine fibroids ... that it had received approval from the US ... study of the Mirabilis System in the United ...
(Date:3/23/2017)... 23, 2017 Mosaic Life Care, based in St. Joseph, Missouri ... across its network of 58 clinics, located in 22 cities, and its flagship St. ... ways to improve the delivery of health care to its patients, including the insurance, ... ... Mosaic Life Care St. Joseph Medical Center ...
Breaking Medicine Technology:
(Date:3/24/2017)... SC (PRWEB) , ... March 24, 2017 , ... Digital ... is excited to announce the opening of a Greenville, South Carolina location. ... for digital progress in Greenville. , “We’ve been working with South Carolina clients for ...
(Date:3/24/2017)... , ... March 24, 2017 , ... The iaedp Foundation, ... other medical professionals caring for those suffering from the full spectrum of disordered eating, ... as eating disorders professionals from nearly all 50 states and several countries converged on ...
(Date:3/24/2017)... PA (PRWEB) , ... March 24, 2017 , ... ... Oncology Nursing Society (ONS) wanted to create a communications platform that positions them ... this goal, Elliance and ONS reinvented their online publication as an always-on, always-fresh ...
(Date:3/24/2017)... , ... March 24, 2017 , ... Viewers who like ... of critical historical facts, cultural practices, goods, services, and societal issues tend to appreciate ... look into the popular practice of utilizing running events for causes around the world. ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding ... God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion with ... Walk with God #TruthwithGrace” is the creation of published author Lea Michelle Johnson, ...
Breaking Medicine News(10 mins):